Parmesh Gajjar

Chief Technology Officer

Infex Therapeutics

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Parmesh Gajjar is the Chief Technology Officer at InformiX Pharma Limited in the UK. His research areas encompass the structural and morphologic properties of pharmaceutical powders, with a particular focus on inhalation blends and bioequivalence. Recent publications include studies on α-lactose monohydrate and its applications in drug formulations, as well as advanced imaging techniques for understanding powder characteristics.

Articles (10)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Andrew Hooker

Professor of Pharmacometrics

Uppsala University

SWEDEN

View details

Darragh Murnane

University of Hertfordshire

UNITED KINGDOM

View details

William Parnell

The University of Manchester

UNITED KINGDOM

View details

Hitesh Mistry

The University of Manchester

UNITED KINGDOM

View details

James E. Polli

UNITED STATES

View details

Chris Johnson

Reader in Nonlinear Dynamics

The University of Manchester

UNITED KINGDOM

View details

Jogarao Gobburu

Professor

University of Maryland

UNITED STATES

View details

John Gray

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Parmesh Gajjar

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Structure, morphology and surface properties of α-lactose monohydrate in relation to its powder properties

Understanding the agglomerate crystallisation of hexamine through X-ray microscopy and crystallographic modelling

Establishing the suitability of model‐integrated evidence to demonstrate bioequivalence for long‐acting injectable and implantable drug products: Summary of workshop

Predicting the Strength of Cohesive and Adhesive Interparticle Interactions for Dry Powder Inhalation Blends of Terbutaline Sulfate with α-Lactose Monohydrate

Microstructural insight into inhalation powder blends through correlative multi-scale X-ray computed tomography

Determining bioequivalence possibilities of long acting injectables through population PK modelling

Population PK modelling as an alternative route to bioequivalence

Geometrical and mechanical characterisation of hollow thermoplastic microspheres for syntactic foam applications

Size segregation of irregular granular materials captured by time-resolved 3D imaging

Unlocking secrets of inhalation blends through X-ray Computed Tomography and Microscopy

Collaborators (8)

Andrew Hooker

Darragh Murnane

William Parnell

Hitesh Mistry

James E. Polli

Chris Johnson

Jogarao Gobburu

John Gray

Make your next move.